Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues in pediatric asthma.

P J Helms1

  • 1Department of Child Health, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK. http://www.abdn.ac.uk/child health/chindex.htm

Pediatric Pulmonology. Supplement
|July 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Core requirements for successful data linkage: an example of a triangulation method.

BMJ open·2016
Same author

Linking NHS data for pediatric pharmacovigilance: Results of a Delphi survey.

Research in social & administrative pharmacy : RSAP·2015
Same author

Views of healthcare professionals to linkage of routinely collected healthcare data: a systematic literature review.

Journal of the American Medical Informatics Association : JAMIA·2013
Same author

Population pharmacokinetics of single-dose intravenous paracetamol in children.

British journal of anaesthesia·2012
Same author

A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids.

Archives of disease in childhood·2010
Same author

Changes in the prevalence of asthma, eczema and hay fever in pre-pubertal children: a 40-year perspective.

Paediatric and perinatal epidemiology·2009
Same journal

Outcome after Liver Transplantation for Cystic Fibrosis.

Pediatric pulmonology. Supplement·2011
Same journal

Abstracts of the 23rd Annual North American Cystic Fibrosis Conference, Minneapolis, Minnesota, USA, October 15-17, 2009.

Pediatric pulmonology. Supplement·2009
Same journal

Abstracts of the 21st Annual North American Cystic Fibrosis Conference, October 23-25, 2008, Orlando, Florida, USA.

Pediatric pulmonology. Supplement·2008
Same journal

Abstracts of the 21st Annual North American Cystic Fibrosis Conference, October 3-6, 2007, Anaheim, California, USA.

Pediatric pulmonology. Supplement·2007
Same journal

Abstracts of the 20th Annual North American Cystic Fibrosis Conference, November 2-5, 2006, Denver, Colorado, USA.

Pediatric pulmonology. Supplement·2006
Same journal

Abstracts of the 19th Annual North American Cystic Fibrosis Conference, Baltimore, Maryland, USA, October 20-23, 2005.

Pediatric pulmonology. Supplement·2005
See all related articles

Diagnosing asthma in young children is challenging due to similar symptoms. Delaying inhaled corticosteroid (ICS) therapy until a clear diagnosis is established may be best, considering alternatives for mild cases.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Clinical Therapeutics

Background:

  • Wheezing syndromes in young children are often misdiagnosed as asthma.
  • Accurate differential diagnosis is crucial for effective treatment and improved outcomes.
  • Inhaled corticosteroids (ICS) are standard for persistent pediatric asthma but raise concerns about overuse.

Purpose of the Study:

  • To address the diagnostic challenges in differentiating pediatric asthma from other wheezing disorders.
  • To evaluate the appropriateness of early and long-term inhaled corticosteroid (ICS) use in young children.
  • To explore alternative treatments for mild asthma in pediatric populations.

Main Methods:

  • Review of clinical presentations, pathophysiology, and disease evolution of pediatric wheezing disorders.

Related Experiment Videos

  • Analysis of current treatment guidelines and evidence for inhaled corticosteroids (ICS) in pediatric asthma.
  • Consideration of alternative therapeutic options, such as leukotriene receptor antagonists.

    • Main Results:

    • Differentiating asthma from other wheezing disorders in young children is complex due to overlapping symptoms.
    • Evidence supports ICS benefits in persistent pediatric asthma, but concerns exist regarding overuse in milder cases.
    • Delayed ICS initiation until definitive diagnosis may prevent unnecessary steroid exposure.

    Conclusions:

    • Accurate differential diagnosis is essential for managing pediatric wheezing disorders.
    • Clinicians should consider delaying regular ICS therapy in young children until a definitive asthma diagnosis is confirmed.
    • Alternative treatments should be explored to mitigate potential side effects of ICS in mild pediatric asthma.